Talis Biomedical Corp Quarterly Operating Margin in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Talis Biomedical Corp quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q2 2024.
  • Talis Biomedical Corp Operating Margin for the quarter ending June 30, 2024 was -13.5K %, a 327% decline year-over-year.
  • Talis Biomedical Corp annual Operating Margin for 2023 was -3.13K %, a 30.9% decline from 2022.
  • Talis Biomedical Corp annual Operating Margin for 2022 was -2.39K %, a 2.2% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -13.5K -10.3K -327% Apr 1, 2024 Jun 30, 2024
Q1 2024 -6.26K -2.7K -76% Jan 1, 2024 Mar 31, 2024
Q4 2023 -3.13K -738 -30.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -3.66K -1.53K -71.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.17K -535 -20.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -3.56K +192 +5.11% Jan 1, 2023 Mar 31, 2023
Q4 2022 -2.39K -51.5 -2.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.13K Jul 1, 2022 Sep 30, 2022
Q2 2022 -2.63K Apr 1, 2022 Jun 30, 2022
Q1 2022 -3.75K Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.34K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.